Evidence map›Paper›PMID 26743170›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2016

MicroRNA-150 Suppression of Angiopoetin-2 Generation and Signaling Is Crucial for Resolving Vascular Injury.

Charu Rajput, Mohammad Tauseef, Mohammad Farazuddin, Pascal Yazbeck, Md-Ruhul Amin, Vijay Avin Br, Tiffany Sharma, Dolly Mehta

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. MicroRNAs in Sepsis.Biomedicines · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Role of miRNA dysregulation in sepsis.Molecular medicine (Cambridge, Mass.) · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Charu RajputFrom the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois at Chicago.
Mohammad TauseefFrom the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois at Chicago.
Mohammad FarazuddinFrom the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois at Chicago.
Pascal YazbeckFrom the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois at Chicago.
Md-Ruhul AminFrom the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois at Chicago.
Vijay Avin BrFrom the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois at Chicago.
Tiffany SharmaFrom the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois at Chicago.
Dolly MehtaFrom the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois at Chicago. dmehta@uic.edu.
University of Illinois Chicago · USNorthwestern University · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
Trpm2 Regulation of Phagocyte Bactericidal Activity and Resolution of Lung InjuryP01HL077806 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2005 to 2019
$27.0M
TRAINING PROGRAM IN LUNG BIOLOGY AND PATHOBIOLOGYT32HL007829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOLLY MEHTA · 1995 to 2026
$15.6M
Focal Adhesion Kinase Regulation of Lung Vascular Permeability and EdemagenesisR01HL084153 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, DOLLY · 2007 to 2022
$5.4M
Rho Regulation of Pulmonary Vascular PermeabilityR01HL071794 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, DOLLY · 2003 to 2013
$3.2M
NHLBI NIH HHS HL060678NHLBI NIH HHS HL71794NHLBI NIH HHS HL84153NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL077806NHLBI NIH HHS R01 HL071794NHLBI NIH HHS R01 HL084153NHLBI NIH HHS T32 HL007829
6 · The paper itself

Abstract

objectiveIncreased vascular permeability is a hallmark of sepsis and acute respiratory distress syndrome. Angiopoietin (Ang2) induces vascular leak, and excess Ang2 generation is associated with patient mortality from these diseases. However, mechanisms dampening Ang2 generation during injury remain unclear. Interestingly, microRNA (miR)-150 levels were decreased in septic patients. miR regulate signaling networks by silencing mRNAs containing complementary sequences. Thus, we hypothesized that miR-150 suppresses Ang2 generation and thereby resolves vascular injury. APPROACH AND

resultsWild-type or miR-150(-/-) mice or endothelial cells were exposed to lipopolysaccharide or sepsis, and Ang2 levels, adherens junction reannealing, endothelial barrier function, and mortality were determined. Although Ang2 transiently increased during lipopolysaccharide-induced injury in wild-type endothelial cells and lungs, miR-150 expression was elevated only during recovery from injury. Deletion of miR-150 caused a persistent increase in Ang2 levels and impaired adherens junctions reannealing after injury, resulting thereby in an irreversible increase in vascular permeability. Also, miR-150(-/-) mice died rapidly after sepsis. Rescuing miR-150 expression in endothelial cells prevented Ang2 generation, thereby restoring vascular barrier function in miR-150(-/-) mice. miR-150 terminated Ang2 generation by targeting the transcription factor, early growth response 2. Thus, early growth response 2 or Ang2 depletion in miR-150(-/-) endothelial cells restored junctional reannealing and reinstated barrier function. Importantly, upregulating miR-150 expression by injecting a chemically synthesized miR-150 mimic into wild-type mice vasculature decreased early growth response 2 and Ang2 levels and hence mortality from sepsis.

conclusionsmiR-150 is a novel suppressor of Ang2 generation with a key role in resolving vascular injury and reducing mortality resulting from sepsis.

Indexed as

Vascular RemodelingAdherens JunctionsAngiopoietin-2AnimalsCapillary PermeabilityCells, CulturedDisease Models, AnimalEarly Growth Response Protein 2Endothelial CellsGene Expression RegulationGenotypeLipopolysaccharidesMice, Inbred C57BLMice, KnockoutMicroRNAsPhenotypeAngiopoietin-2ANGPT2 protein, humanEarly Growth Response Protein 2EGR2 protein, humanLipopolysaccharidesMicroRNAsMIR150, humanMirn150 microRNA, mouseadherens junctionsangiopoietin 2endothelial growth response 2endotheliumlung injurymiR-150sepsis

Identifiers

PMID26743170
PMCPMC4732888
OpenAlexW2227349149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.